Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Rehab for lungs and heart: a new hope for COPD patients with high blood pressure in the lungs?

NCT ID NCT07202793

Knowledge-focused Sponsor: Poitiers University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviewed medical records of 59 adults with COPD to see if a standard pulmonary rehabilitation program is safe and effective for those who also have pulmonary hypertension (high blood pressure in the lungs). Researchers compared how much walking distance improved in people with and without pulmonary hypertension after completing at least three weeks of rehab. The goal is to understand if this common treatment works equally well for both groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

59 people

The number who actually took part.

Started

Sep 2021

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The source population consists of adults (18 years and older) with spirometry-confirmed chronic obstructive pulmonary disease who attended at least three consecutive weeks of supervised outpatient pulmonary rehabilitation at the University Hospital of Poitiers (France) between January 2013 and December 2023. Every individual had a six-minute walk test recorded both immediately before the programme and during its final week, plus a transthoracic echocardiogram performed within one year before or after programme start to grade the probability of pulmonary hypertension. Most candidates were current or former smokers with moderate-to-severe airflow limitation and common cardiometabolic or sleep-related comorbidities. Patients are classified into two analytic cohorts-COPD with pulmonary hypertension and COPD without pulmonary hypertension-according to their echocardiographic findings.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Spirometry-confirmed chronic obstructive pulmonary disease with a post-bronchodilator FEV1 / FVC ratio below 0 .70 * Completion of at least three consecutive weeks of outpatient pulmonary rehabilitation between January 2013 and December 2023 at the University - Hospital of Poitiers centre * Six-minute walk test performed within seven days before programme start and repeated during the final week * Transthoracic echocardiogram carried out within one year before or one year after programme start, used to grade pulmonary hypertension Exclusion Criteria: * Pulmonary rehabilitation shorter than three weeks or missing six-minute walk test or echocardiogram data * Chronic lung disease other than chronic obstructive pulmonary disease or previous lung transplantation -,Hospital admission for an acute chronic obstructive pulmonary disease exacerbation in the four weeks preceding rehabilitation * Unstable cardiovascular disease that contraindicates exercise training * Active cancer with an expected survival under one year * Pregnancy at the time of rehabilitation * Documented refusal to allow medical data to be used for research

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset lung disorder pulmonary hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD Pulmonary hypertension

Contacts and locations

Locations

  • CHU de Poitiers, University of Poitiers, France

    Poitiers, Vienne, 86000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.